Scotland's position is unusual and easy to miss, because most UK coverage of ketamine treatment is written from England. The essential fact is that a devolved medicines decision went the other way here: where NICE said no, the Scottish Medicines Consortium said yes with restrictions, so an NHS-funded route exists in Scotland that does not exist in England, Wales or Northern Ireland. This guide sets out what that route covers, what it does not, and what the private and research options look like from Edinburgh or Glasgow.
TL;DR The NHS route in Scotland is esketamine (Spravato), accepted by the SMC for restricted use in treatment-resistant depression and delivered via psychiatrist assessment and local health board arrangements — start by asking your psychiatrist, with a written treatment history in hand. Racemic ketamine infusions are not routinely funded by the NHS anywhere in the UK, so infusions and ketamine-assisted psychotherapy in Scotland are private and self-pay at roughly £300–800 per infusion, or from about £6,000 for a full programme. Trials in Edinburgh and Glasgow are recruiting and free.
The routes at a glance
| NHS esketamine (Scotland) | Private ketamine or KAP | NHS trust, self-funded (Oxford) | Clinical trial | |
|---|---|---|---|---|
| What it is | Spravato nasal spray under supervision, alongside a continuing oral antidepressant | Off-label IV ketamine infusions, sometimes with preparation and integration therapy | Off-label IV ketamine inside an NHS trust's own service | Study medicine under research protocol |
| Who can use it | Treatment-resistant depression assessed by a psychiatrist under SMC restrictions and health board arrangements | Anyone passing the clinic's medical screening; self-referral widely accepted | Anyone with a referral letter from a GP or psychiatrist, subject to the service's intake rules | Study-specific criteria; strict screening |
| Cost | Covered by NHS Scotland | £300–800 per infusion; programmes from ~£6,000 | £265 per infusion and per initial assessment; budget ~£3,000/year | Free |
| How to start | Ask your psychiatrist about the pathway in your health board area | Contact the clinic directly | GP or psychiatrist referral letter, then an assessment usually held online | Registry search plus screening |
The NHS route: esketamine, via your psychiatrist
The Scottish Medicines Consortium accepted esketamine (SMC2258) for restricted use in treatment-resistant depression under a patient access scheme, implemented through the health boards. NICE, by contrast, did not recommend it in TA854 on cost-effectiveness grounds, a decision that applies in England and Wales and which Northern Ireland endorsed. The result is a genuine postcode difference within one licensed medicine — the detail is in our UK reimbursement guide.
What the restriction turns on is documented treatment resistance: no response to at least two adequate antidepressant courses in the current episode. Assessment is by a psychiatrist, and delivery depends on your local health board's arrangements. Two practical implications follow. First, your GP is not the decision-maker but is the door: a referral into secondary care, plus a printout of your medication history, is the useful first ask. Second, the written treatment history — every antidepressant tried in the current episode, with dose, duration and outcome — carries the case. Bring it; it counts for more than anything you say in the room.
If esketamine is approved for you, the sessions are supervised: you self-administer the spray in the clinic, stay for roughly two hours of observation, continue an oral antidepressant alongside, and do not drive until the following day. Our preparation checklist covers the day in detail.
Ketamine infusions: private, and priced like the rest of the UK
The NHS route in Scotland is for esketamine specifically. Racemic ketamine — the generic anaesthetic given as an intravenous infusion — has never been appraised for routine NHS commissioning anywhere in the UK, because its use for depression is off-label. The NHS pilots of racemic ketamine that do exist run at Oxford Health and Central and North West London NHS Foundation Trusts (Magnetar/Blossom reimbursement report, 2025), both in England and reached through NHS referral rather than direct booking.
So in Scotland, infusions and ketamine-assisted psychotherapy mean the private market, on UK terms: roughly £300–800 per infusion, with London typically around £595, and full KAP programmes from about £6,000 for six weeks. Our UK cost comparison and European cost guide collect the published figures.
In our directory, the Scottish private option we have verified is Eulas Clinics in Edinburgh, a ketamine-assisted psychotherapy provider that also lists sites in London and Manchester and publishes a six-week programme from around £6,000. Glasgow is the honest gap: we currently list no private ketamine clinic there — the Glasgow entry in our directory is a hospital trial site, not a treatment service. If you are in the west of Scotland, the realistic private options are travelling to Edinburgh, travelling south, or asking a clinic whether it runs remote consultations with in-person dosing elsewhere. You can compare everything we list at providers in the United Kingdom, and every legal route to ketamine therapy in the UK — including psilocybin and MDMA research — is covered in our UK access guide.
One cross-border option is worth pricing before you commit. Oxford Health NHS Foundation Trust runs a self-funded ketamine service inside the NHS at £265 per infusion and per initial psychiatrist assessment, with £125 per scheduled review, open to patients with a referral letter from a GP or psychiatrist subject to its intake rules — the assessment itself usually happens online, and the service suggests budgeting around £3,000 per year. Genuinely NHS-funded treatment there is limited to Oxfordshire and Buckinghamshire patients referred by its own consultants, but the self-funded route is not catchment-limited. For a Scottish patient a four-to-six-infusion induction at those prices, travel included, may still undercut a private programme at home; whether the therapy layer in a KAP programme is worth the difference is a real clinical question, not a settled one.
Whichever you choose, verify before paying. Independent clinics in Scotland are regulated by the Scottish equivalent of the CQC rather than by the CQC itself, so check the clinic's entry on the relevant national register, check the prescriber on the GMC register, get the full course cost in writing, and ask what maintenance costs after the induction. The full checklist is in our clinic-choice guide.
The research route
If cost is the constraint, trials are free by definition — legitimate studies never charge, and many reimburse travel. Scotland is part of one of Europe's busiest psychedelic research scenes: our directory lists NHS Research Scotland in Edinburgh and Queen Elizabeth University Hospital in Glasgow as sites recruiting for NCT06793397, Cybin's Phase 3 study of the deuterated psilocin analogue CYB003 in major depressive disorder. Across the UK, 67 studies are tracked and 12 are active, spanning psilocybin, ketamine, DMT and esketamine.
Screening is strict and enrolment is never guaranteed, so treat trials as an option to check rather than a plan to rely on. Our trials guide explains how phases, placebo and consent work and how to search the registries.
Frequently asked questions
Can I get ketamine therapy on the NHS in Scotland?
You can get esketamine (Spravato) on the NHS in Scotland if a psychiatrist assesses you as meeting the SMC restrictions for treatment-resistant depression and your health board provides the service. Racemic ketamine infusions are not routinely NHS-funded in Scotland or anywhere else in the UK; the NHS ketamine pilots are in England.
How do I start the NHS esketamine route in Scotland?
Ask your psychiatrist directly about the esketamine pathway in your health board area — do not assume the England picture applies to you. If you are not currently under a psychiatrist, ask your GP for a referral into secondary care and take a written history of every antidepressant tried in the current episode with dose, duration and outcome.
Is there a ketamine clinic in Glasgow?
Not in our directory as of August 2026. The Glasgow record we hold is a hospital trial site rather than a treatment service; the nearest verified private option in Scotland is in Edinburgh. Listings change, so check the UK directory for the current picture before assuming either way.
What does private ketamine therapy cost in Scotland?
At UK market rates: roughly £300–800 per infusion, with full ketamine-assisted psychotherapy programmes from around £6,000 for six weeks. Ask for the full course cost in writing rather than a per-session price, and compare it against the £265 per infusion charged by the NHS trust service in Oxford, which accepts self-funded referrals from outside its area.
Is Spravato the same as ketamine infusions?
No. Spravato is esketamine, an approved nasal-spray medicine with its own EU and UK licence for treatment-resistant depression; racemic ketamine is the older generic anaesthetic used off-label. They differ in approval, funding, setting and cost — see our side-by-side comparison.
Are there ketamine trials in Scotland?
There is an active research route: Edinburgh and Glasgow sites are recruiting for a Phase 3 depression study of a psilocin analogue, and UK-wide the trial scene includes ketamine and esketamine studies. Participation is free, screening is strict, and enrolment is never guaranteed.
Sources
- SMC: Esketamine (Spravato) advice — SMC2258
- NICE TA854: Esketamine nasal spray for treatment-resistant depression — recommendations
- Oxford Health NHS FT: Interventional Psychiatry Service pricing
- Oxford Health NHS FT: Ketamine TRD service
- Eulas Clinics: ketamine therapy pricing
- The Burlington Clinic: ketamine therapy cost in London
- ClinicalTrials.gov: NCT06793397 — CYB003 Phase 3 in major depressive disorder
- Blossom: United Kingdom country report
- Reimbursement Pathways for Psychedelic Therapies in Europe — Magnetar Access × Blossom (2025)
This guide is for general information only and is not medical advice, a diagnosis, or a recommendation of any treatment. Regulations and prices change; always verify a provider's current registration with the relevant regulator, confirm fees in writing, and discuss your options with a licensed clinician who knows your history. If you are in crisis, contact your local emergency number or a crisis line immediately.
This guide awaits review by a licensed medical professional.